MedTrace Logo

The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung

NCT01362114 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2012-04-18

No results posted yet for this study

Summary

In this randomized, double blinded, Placebo-control Trial, the investigators planned to give Sihogayonggolmoryeo-tang extract or controlled medication on the Anxiety of Hwa-byung.

Conditions

  • Hwa-byung

Interventions

DRUG

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks

OTHER

Placebo

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    lead OTHER_GOV

Principal Investigators

  • In-Chul Jung, Ph.D · Oriental Hospital of Daejon University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-05-31
Completion
2012-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01362114 on ClinicalTrials.gov